Kazimierz Węglarczyk

6PUBLICATIONS
16CO-AUTHORS
Rheumatology and arthritisOther biomedical and clinical sciences not elsewhere classifiedAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 28, 2026
Serum Levels of Selected Chemokines in Patients with Systemic Lupus Erythematosus Correlate with Disease Activity and Clinical Features: Results from a Single-Center Observational Study.

Radosław Dziedzic, Andżelika Siwiec-Koźlik, Paweł Koźlik-Siwiec

|Mar 28, 2026
Correction: Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction.

Gabriela Rybka, Radosław Dziedzic, Kazimierz Węglarczyk

|Nov 16, 2025
Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction.

Gabriela Rybka, Radosław Dziedzic, Kazimierz Węglarczyk

|Sep 09, 2025
Serum levels of PECAM-1, ICAM-1, and VCAM-1 in patients with systemic lupus erythematosus: associations with disease activity and clinical features from a single-center study.

Gabriela Rybka, Kazimierz Węglarczyk, Radosław Dziedzic

|Jun 19, 2024
TGF-β Signalling Regulates Cytokine Production in Inflammatory Cardiac Macrophages during Experimental Autoimmune Myocarditis.

Karolina Tkacz, Filip Rolski, Monika Stefańska

|Jul 02, 2021
The Anti-Tumor Effect of Lactococcus lactis Bacteria-Secreting Human Soluble TRAIL Can Be Enhanced by Metformin Both In Vitro and In Vivo in a Mouse Model of Human Colorectal Cancer.

Katarzyna Kaczmarek, Jerzy Więckiewicz, Kazimierz Węglarczyk

Pageof 1

Frequent Collaborators

5 joint publications

Maciej Siedlar

4 joint publications

Radosław Dziedzic

4 joint publications

Mariusz Korkosz

4 joint publications

Joanna Kosałka-Węgiel